Milestone Scientific (MLSS) Halted on LUDP

Go back to Milestone Scientific (MLSS) Halted on LUDP

Milestone Scientific (MLSS) Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. Patent

February 24, 2021 3:16 PM EST

Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) related to its new CompuPulse System, which integrates the Companys CompuWave technology with a manual syringe.

Mark Hochman, D.D.S., Inventor and Clinical Director for Milestone Scientific, commented, "We are pleased to receive... More